Collegium Total Current Assets vs Net Invested Capital Analysis
COLL Stock | USD 34.18 0.32 0.93% |
Collegium Pharmaceutical financial indicator trend analysis is way more than just evaluating Collegium Pharmaceutical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Collegium Pharmaceutical is a good investment. Please check the relationship between Collegium Pharmaceutical Total Current Assets and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
Total Current Assets vs Net Invested Capital
Total Current Assets vs Net Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Collegium Pharmaceutical Total Current Assets account and Net Invested Capital. At this time, the significance of the direction appears to have strong relationship.
The correlation between Collegium Pharmaceutical's Total Current Assets and Net Invested Capital is 0.78. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Collegium Pharmaceutical, assuming nothing else is changed. The correlation between historical values of Collegium Pharmaceutical's Total Current Assets and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Collegium Pharmaceutical are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Total Current Assets i.e., Collegium Pharmaceutical's Total Current Assets and Net Invested Capital go up and down completely randomly.
Correlation Coefficient | 0.78 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most indicators from Collegium Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Collegium Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.At this time, Collegium Pharmaceutical's Tax Provision is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.37 this year, although the value of Selling General Administrative will most likely fall to about 97.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 21.0M | 63.2M | 83.3M | 87.5M | Depreciation And Amortization | 68.9M | 138.9M | 149.3M | 156.7M |
Collegium Pharmaceutical fundamental ratios Correlations
Click cells to compare fundamentals
Collegium Pharmaceutical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Collegium Pharmaceutical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 306.3M | 643.8M | 692.1M | 1.2B | 1.1B | 1.2B | |
Short Long Term Debt Total | 21.6M | 266.6M | 258.8M | 872.8M | 674.3M | 708.0M | |
Other Current Liab | 153.1M | 108.3M | 147.8M | 66.9M | 264.9M | 278.1M | |
Total Current Liabilities | 197.3M | 191.2M | 230.4M | 270.1M | 457.9M | 480.8M | |
Total Stockholder Equity | 87.4M | 186.0M | 202.9M | 194.8M | 195.4M | 127.6M | |
Property Plant And Equipment Net | 20.9M | 27.4M | 27.1M | 26.4M | 22.0M | 13.8M | |
Net Debt | (148.4M) | 92.5M | 72.3M | 699.1M | 435.3M | 457.1M | |
Retained Earnings | (359.9M) | (333.1M) | (256.3M) | (281.3M) | (233.2M) | (244.8M) | |
Accounts Payable | 39.7M | 34.7M | 33.4M | 39.6M | 8.7M | 8.3M | |
Cash | 170.0M | 174.1M | 186.4M | 173.7M | 238.9M | 146.7M | |
Non Current Assets Total | 50.6M | 366.0M | 376.5M | 754.1M | 605.7M | 636.0M | |
Non Currrent Assets Other | 178K | 2.7M | 87K | 100K | 825.0K | 488K | |
Other Assets | 178K | 11.1K | 942.7M | 19.3M | 22.2M | 21.1M | |
Long Term Debt | 7.7M | 209.6M | 201.6M | 538.5M | 483.8M | 508.0M | |
Cash And Short Term Investments | 170.0M | 174.1M | 186.4M | 173.7M | 310.5M | 326.1M | |
Common Stock Total Equity | 34K | 35K | 36K | 37K | 42.6K | 29.4K | |
Common Stock Shares Outstanding | 33.5M | 35.2M | 41.0M | 33.8M | 41.8M | 30.1M | |
Liabilities And Stockholders Equity | 306.3M | 643.8M | 692.1M | 1.2B | 1.1B | 1.2B | |
Non Current Liabilities Total | 21.6M | 266.6M | 258.8M | 709.2M | 490.0M | 514.5M | |
Other Current Assets | 141K | 60K | 27K | 16.7M | 93K | 88.4K | |
Other Stockholder Equity | 447.3M | 519.1M | 459.2M | 476.1M | 428.6M | 374.3M | |
Total Liab | 218.9M | 457.8M | 489.1M | 979.3M | 947.9M | 995.3M | |
Property Plant And Equipment Gross | 20.9M | 27.4M | 27.1M | 26.4M | 31.7M | 33.3M | |
Total Current Assets | 255.7M | 277.9M | 315.5M | 420.0M | 537.6M | 564.5M | |
Accumulated Other Comprehensive Income | (1.7M) | (1.8M) | (2.3M) | 0.0 | 14K | 14.7K | |
Short Term Debt | 4.5M | 48.2M | 49.2M | 163.6M | 184.3M | 193.5M | |
Common Stock | 34K | 35K | 36K | 37K | 38K | 30.5K | |
Property Plant Equipment | 20.9M | 19.0M | 19.5M | 19.5M | 22.4M | 23.6M | |
Net Tangible Assets | 57.9M | (149.9M) | (65.8M) | (506.3M) | (455.7M) | (432.9M) | |
Net Receivables | 73.0M | 83.3M | 105.8M | 183.1M | 179.5M | 188.5M | |
Inventory | 9.6M | 15.6M | 17.4M | 46.5M | 32.3M | 33.9M | |
Short Long Term Debt | 3.8M | 47.5M | 48.4M | 162.5M | 183.3M | 192.5M | |
Intangible Assets | 29.5M | 335.9M | 268.7M | 567.5M | 421.7M | 442.8M | |
Retained Earnings Total Equity | (359.9M) | (333.1M) | (256.3M) | (281.3M) | (253.2M) | (265.9M) | |
Long Term Debt Total | 7.7M | 209.6M | 201.6M | 538.5M | 619.2M | 650.2M | |
Capital Surpluse | 447.3M | 519.1M | 502.1M | 538.1M | 618.8M | 468.8M | |
Non Current Liabilities Other | 9.4M | 8.8M | 8.0M | 7.1M | 8.2M | 6.2M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Collegium Pharmaceutical using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 2.51 | Revenue Per Share 17.054 | Quarterly Revenue Growth 0.001 | Return On Assets 0.1056 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.